Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

150 Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin J a et al. A critical
evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of
defined specificities. II. Potential for quantitation of antibody content. J Rheumatol 2002;
29: 68–74.
151 Lerner MR, Steitz J a. Antibodies to small nuclear RNAs complexed with proteins are
produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 1979;
76: 5495–5499.
152 Aziz K, Faizal A. The role of the clinical immunology laboratory in the diagnosis and
monitoring of connective tissue diseases. Saudi Med J 2001; 44: 1796–1807.
153 Ward M, Studenski S. Clinical manifestations of systemic lupus erythematosus:
identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 849–853.
154 Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL et al.
Differences by race, sex and age in the clinical and immunologic features of recently
diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus
2002; 11: 161–167.
155 Isenberg D, Garton M, Reichlin MW, Reichlin M. Long-term follow-up of autoantibody
profiles in black female lupus patients and clinical comparison with Caucasian and Asian
patients. Br J Rheumatol 1997; 36: 229–233.
156 Arnett F, Hamilton R, Roebber M, Harley J, Reichlin M. Increased frequencies of Sm and
nRNP autoantibodies in American blacks compared to whites with systemic lupus
erythematosus. J Rheumatol 1988; 15: 1773–1776.
157 Field M, Williams DG, Charles P, Maini RN. Specificity of anti-Sm antibodies by ELISA
for systemic lupus erythematosus: increased sensitivity of detection using purified peptide
antigens. Ann Rheum Dis 1988; 47: 820–825.
158 Copple S, Martins T, Masterson C, Joly E, Hill H. Comparison of three multiplex
immunoassays for detection of antibodies to extractable nuclear antibodies using clinically.
Ann N Y Acad Sci 2007; 1109: 464–472.
159 P tová I, Dostal C, Becvar R. Prevalence of antinucleosome antibodies by enzyme-linked
immunosorbent assays in patients with systemic lupus erythematosus and other
autoimmune systemic diseases. Ann N Y Acad Sci 2007; 1109: 275–286.
160 Carmona-Fernandes D, Santos MJ, Canhão H, Fonseca JE. Anti-ribosomal P protein IgG
autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and
clinical profile. BMC Med 2013; 11: 98.
161 Barkhudarova F, Dähnrich C, Rosemann A, Schneider U, Stöcker W, Burmester G-R et
al. Diagnostic value and clinical laboratory associations of antibodies against recombinant
ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort
with systemic lupus erythematosus. Arthritis Res Ther 2011; 13: R20.
162 Ghirardello a, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti-ribosomal P
protein antibodies detected by immunoblotting in patients with connective tissue diseases:
446 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS